JNK As a Biomarker of Relapse and Response to Treatment with Glatiramer Acetate in Multiple Sclerosis

被引：0
|
作者：
Anselmo, Freidrich [1 ]
Tatomir, Alexandru [1 ]
Ciriello, Jonathan [1 ]
Rus, Horea [2 ]
机构：
[1] Univ Maryland, Sch Med, Baltimore, MD 21201 USA
[2] Vet Adm Multiple Sclerosis Ctr Excellence East, Baltimore, MD USA
来源：
MULTIPLE SCLEROSIS JOURNAL | 2019年 / 25卷
关键词：
D O I：
暂无
中图分类号：
R74 [神经病学与精神病学];
学科分类号：
摘要：
P016
引用
收藏
页码：26 / 26
页数：1
相关论文
共 50 条
  • [1] JNK as a biomarker of relapse and response to treatment in multiple sclerosis
    Rus, H.
    Anselmo, F.
    Tatomir, A.
    Boodhoo, B.
    Rus, V.
    JOURNAL OF THE NEUROLOGICAL SCIENCES, 2019, 405
  • [2] RGC-32 as a potential biomarker of relapse and response to treatment with glatiramer acetate in multiple sclerosis
    Kruszewski, Adam M.
    Rao, Gautam
    Tatomir, Alexandru
    Hewes, Daniel
    Tegla, Cosmin A.
    Cudrici, Cornelia D.
    Vingh Nguyen
    Royal, Walter, III
    Bever, Christopher T., Jr.
    Rus, Violeta
    Rus, Horea
    EXPERIMENTAL AND MOLECULAR PATHOLOGY, 2015, 99 (03) : 498 - 505
  • [3] Phosphorylated SIRT1 as a biomarker of relapse and response to treatment with glatiramer acetate in multiple sclerosis
    Ciriello, Jonathan
    Tatomir, Alexandru
    Hewes, Daniel
    Boodhoo, Dallas
    Anselmo, Freidrich
    Rus, Violeta
    Rus, Horea
    EXPERIMENTAL AND MOLECULAR PATHOLOGY, 2018, 105 (02) : 175 - 180
  • [4] SIRT1 as a potential biomarker of response to treatment with glatiramer acetate in multiple sclerosis
    Hewes, Daniel
    Tatomir, Alexandru
    Kruszewski, Adam M.
    Rao, Gautam
    Tegla, Cosmin A.
    Ciriello, Jonathan
    Vingh Nguyen
    Royal, Walter, III
    Bever, Christopher
    Rus, Violeta
    Rus, Horea
    EXPERIMENTAL AND MOLECULAR PATHOLOGY, 2017, 102 (02) : 191 - 197
  • [5] RGC-32 as a potential marker of relapse and response to treatment with glatiramer acetate in multiple sclerosis
    Rus, H.
    Kruszewski, A.
    Cudrici, C.
    Nguyen, V.
    Royal, W.
    Bever, C.
    Rus, V.
    JOURNAL OF THE NEUROLOGICAL SCIENCES, 2015, 357 : E17 - E17
  • [6] Glatiramer Acetate in the Reduction of Relapse Frequency in Multiple Sclerosis
    Miravalle, Augusto
    Hendin, Barry
    Vollmer, Timothy L.
    Kala, Mrinalini
    CLINICAL MEDICINE INSIGHTS-THERAPEUTICS, 2011, 3 : 151 - 158
  • [7] Glatiramer acetate in the treatment of multiple sclerosis
    Miller, AE
    NEUROLOGIC CLINICS, 2005, 23 (01) : 215 - +
  • [8] Glatiramer acetate for the treatment of multiple sclerosis
    Wolinsky, JS
    EXPERT OPINION ON PHARMACOTHERAPY, 2004, 5 (04) : 875 - 891
  • [9] Monitoring Glatiramer Acetate treatment in multiple sclerosis
    Farina, C
    Hohlfeld, R
    NEUROLOGY, 2002, 58 (07) : A246 - A246
  • [10] The pharmacokinetics of glatiramer acetate for multiple sclerosis treatment
    Messina, Silvia
    Patti, Francesco
    EXPERT OPINION ON DRUG METABOLISM & TOXICOLOGY, 2013, 9 (10) : 1349 - 1359
12345